These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7407365)

  • 1. [Mechanisms of neuro-tropic disorders induced in skeletal muscles by botulinum toxin].
    Mikhaĭlov VV
    Biull Eksp Biol Med; 1980 Jul; 89(7):25-7. PubMed ID: 7407365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cytostatics on the development of denervation disorders in skeletal muscles].
    Mikhaĭlov VV
    Biull Eksp Biol Med; 1981 Nov; 92(11):537-9. PubMed ID: 6274447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of disorders in neurotrophic regulation of the level of striated skeletal muscle polarization by botulinum toxin].
    Mikhaĭlov VV
    Biull Eksp Biol Med; 1980 Mar; 89(3):276-8. PubMed ID: 6248142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of the functional transformation of paralyzed intercostal muscles in rats with experimental botulism].
    Mikhaĭlov VV; Iakovlev VF
    Biull Eksp Biol Med; 1981 Jun; 91(6):666-8. PubMed ID: 7272481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sorption of vital dyes by skeletal muscles as related to the activity of tetanic and tonic nerve muscle apparatus].
    Mikhaĭlov VV; Teplyĭ DL
    Tsitologiia; 1966; 8(1):38-45. PubMed ID: 5977919
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the electrogenic properties of striated muscle fibers during experimental botulism].
    Morrison VV
    Biull Eksp Biol Med; 1977 Sep; 84(9):262-4. PubMed ID: 912072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro characterization of botulinum toxin types A, C and D action on human tissues: combined electrophysiologic, pharmacologic and molecular biologic approaches.
    Coffield JA; Bakry N; Zhang RD; Carlson J; Gomella LG; Simpson LL
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1489-98. PubMed ID: 9067339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe botulism after focal injection of botulinum toxin.
    Souayah N; Karim H; Kamin SS; McArdle J; Marcus S
    Neurology; 2006 Nov; 67(10):1855-6. PubMed ID: 17130423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human type A botulism and treatment with 3,4-diaminopyridine.
    Davis LE; Johnson JK; Bicknell JM; Levy H; McEvoy KM
    Electromyogr Clin Neurophysiol; 1992; 32(7-8):379-83. PubMed ID: 1526219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of guanidine and germine on the neuromuscular block of botulism.
    Cherington M; Soyer A; Greenberg H
    Curr Ther Res Clin Exp; 1972 Feb; 14(2):91-4. PubMed ID: 4335307
    [No Abstract]   [Full Text] [Related]  

  • 11. Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy.
    Durham PL; Cady R; Cady R
    Headache; 2004 Jan; 44(1):35-42; discussion 42-3. PubMed ID: 14979881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of paradoxical resistance of the digastric muscle to the action of tetanus toxin].
    Mikhaĭlov VV; Shubin AI
    Biull Eksp Biol Med; 1987 May; 103(5):534-6. PubMed ID: 3593917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuro-muscular defect in human botulism.
    Mayer RF
    Electroencephalogr Clin Neurophysiol; 1968 Oct; 25(4):397. PubMed ID: 4176563
    [No Abstract]   [Full Text] [Related]  

  • 14. Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.
    Ribchester RR; Thomson D; Wood NI; Hinks T; Gillingwater TH; Wishart TM; Court FA; Morton AJ
    Eur J Neurosci; 2004 Dec; 20(11):3092-114. PubMed ID: 15579164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of the contractile function of masseter muscles in experimental rat botulism].
    Mikhaĭlov VV; Agaev NE
    Biull Eksp Biol Med; 1980; 89(1):10-2. PubMed ID: 7378558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of botulinus toxin on oxygen utilization in different types of skeletal muscles].
    Chesnokova NP; Alaeva IV; Astaf'eva OG
    Vopr Med Khim; 1980; 26(5):612-6. PubMed ID: 7423875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination of superfluous neuromuscular junctions in rat calf muscles recovering from botulinum toxin-induced paralysis.
    Hassan SM; Jennekens FG; Wieneke G; Veldman H
    Muscle Nerve; 1994 Jun; 17(6):623-31. PubMed ID: 8196705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of human botulism.
    Maselli RA
    Ann N Y Acad Sci; 1998 May; 841():122-39. PubMed ID: 9668232
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum neurotoxin: the neuromuscular junction revisited.
    Coffield JA
    Crit Rev Neurobiol; 2003; 15(3-4):175-96. PubMed ID: 15248810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of botulinum toxin type A on intracortical inhibition in patients with dystonia.
    Gilio F; Currà A; Lorenzano C; Modugno N; Manfredi M; Berardelli A
    Ann Neurol; 2000 Jul; 48(1):20-6. PubMed ID: 10894212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.